Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × UM-Chor1, DARPin_E3_5, vs 3 × UM-Chor1, T-DARPin_A2, vs 3 × UM-Chor1, T-DARPin_B1, vs 3 × UM-Chor1, T-DARPin_D4,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordomaScience advances · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE276715_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1158741 and SRA study SRP531516. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8504446 UM-Chor1, DARPin_E3_5, rep1 UM-Chor1, DARPin_E3_5,
- GSM8504447 UM-Chor1, DARPin_E3_5, rep2 UM-Chor1, DARPin_E3_5,
- GSM8504448 UM-Chor1, DARPin_E3_5, rep3 UM-Chor1, DARPin_E3_5,
- GSM8504449 UM-Chor1, T-DARPin_A2, rep1 UM-Chor1, T-DARPin_A2,
- GSM8504450 UM-Chor1, T-DARPin_A2, rep2 UM-Chor1, T-DARPin_A2,
- GSM8504451 UM-Chor1, T-DARPin_A2, rep3 UM-Chor1, T-DARPin_A2,
- GSM8504452 UM-Chor1, T-DARPin_B1, rep1 UM-Chor1, T-DARPin_B1,
- GSM8504453 UM-Chor1, T-DARPin_B1, rep2 UM-Chor1, T-DARPin_B1,
- GSM8504454 UM-Chor1, T-DARPin_B1, rep3 UM-Chor1, T-DARPin_B1,
- GSM8504455 UM-Chor1, T-DARPin_D4, rep1 UM-Chor1, T-DARPin_D4,
- GSM8504456 UM-Chor1, T-DARPin_D4, rep2 UM-Chor1, T-DARPin_D4,
- GSM8504457 UM-Chor1, T-DARPin_D4, rep3 UM-Chor1, T-DARPin_D4,
- GSE285857 Mutant KRAS-Driven Selective mRNA Translation Reveals Mechanisms and Therapeutic Vulnerabilities in Cancer 48 samples shares vulnerabilities, therapeutic, selective
- GSE294016 A macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer [bulk RNA-seq] 95 samples shares vulnerabilities, therapeutic
- GSE335924 RNA-seq Identifies FOS as a Potential Therapeutic Target Activating Neural Stem Cells via miR-21/SOX2 Pathway in Hypertensive Intracerebral Hemorrhage 53 samples shares therapeutic, identifies
- GSE241989 Immunotherapeutic targeting of surfaceome heterogeneity in AML 18 samples shares therapeutic, targeting
- GSE210098 Glomerular transcriptomics predicts outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy 17 samples shares therapeutic, identifies
- GSE298578 Single cell RNA profiling of blood CD4+ T cells identifies distinct helper and dysfunctional regulatory clusters in children with SLE (5' PBMC validation dataset) 14 samples shares identifies, regulatory
- GSE269942 YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities 12 samples shares vulnerabilities, therapeutic
- GSE293843 Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors [RNA-Seq] 10 samples shares therapeutic, targeting
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.